Plasmalogens are membrane fats that decline with age and run low in dementia and coronary disease. Marine extracts and gram-scale oils raise blood levels. What that does for thinking, mood, walking, or heart-related blood fats is much less settled. Short-term safety is uneventful aside from gastrointestinal adverse events with high-dose oils. Still-unproven restoration strategy; extra healthy years are not proven. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Blood ethanolamine and choline plasmalogens | No established functional range; track change from personal baseline and any age-matched lab reference | Confirms the product raises circulating species |
| Fasting triglycerides | Often <100 mg/dL in functional practice (conventional <150 mg/dL) | Alkylglycerol oil lowered triglycerides in one small trial |
| High-sensitivity C-reactive protein | Often <1.0 mg/L functionally (conventional <3.0 mg/L) | Same trial lowered this inflammation marker |
| Mini-Mental State Examination or Montreal Cognitive Assessment | Change from personal baseline; no plasmalogen-specific target | Named scales used in human trials |
Cadence: Baseline fasting ether-lipid panel with triglycerides and high-sensitivity C-reactive protein; add a named cognitive scale when memory is the reason. Repeat the plasmalogen panel and lipids at 4 weeks, again at 12 weeks, then every 6–12 months if use continues. Repeat cognitive scales at 12–24 weeks.